Stock Analysts’ Updated EPS Estimates for May 11th (ASC, AV, BRBY, BYIT, CGON, CHYM, CNA, CON, CPG, DCGO)

Stock Analysts’ updated eps estimates for Monday, May 11th:

ASOS (LON:ASC) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 600 target price on the stock.

Aviva (LON:AV) had its buy rating reaffirmed by analysts at UBS Group AG. The firm currently has a GBX 750 target price on the stock.

Burberry Group (LON:BRBY) had its buy rating reaffirmed by analysts at UBS Group AG. The firm currently has a GBX 1,410 target price on the stock.

Bytes Technology Group (LON:BYIT) had its neutral rating reiterated by analysts at UBS Group AG. They currently have a GBX 305 price target on the stock.

CG Oncology (NASDAQ:CGON) had its buy rating reiterated by analysts at Truist Financial Corporation. They currently have a $77.00 price target on the stock, up from their previous price target of $75.00.

Chime Financial (NASDAQ:CHYM) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a $40.00 target price on the stock.

Centrica (LON:CNA) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 225 target price on the stock.

Concentra Group Holdings Parent (NYSE:CON) had its buy rating reiterated by analysts at Truist Financial Corporation. They currently have a $31.00 target price on the stock, up from their previous target price of $29.00.

Compass Group (LON:CPG) had its buy rating reissued by analysts at UBS Group AG.

Compass Group (LON:CPG) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd.

DocGo (NASDAQ:DCGO) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald.

DraftKings (NASDAQ:DKNG) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $35.00 price target on the stock.

Derwent London (LON:DLN) had its sell rating reissued by analysts at UBS Group AG. They currently have a GBX 1,650 target price on the stock.

Denali Therapeutics (NASDAQ:DNLI) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $39.00 target price on the stock.

FedEx (NYSE:FDX) had its buy rating reiterated by analysts at Barclays PLC.

Fluor (NYSE:FLR) had its buy rating reaffirmed by analysts at Truist Financial Corporation. The firm currently has a $57.00 target price on the stock, down from their previous target price of $59.00.

Galliford Try (LON:GFRD) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 650 target price on the stock.

General Motors (NYSE:GM) (TSE:GMM.U) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $95.00 price target on the stock.

Genus (LON:GNS) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 3,350 target price on the stock.

Greggs (LON:GRG) had its buy rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 2,200 target price on the stock.

Goodyear Tire & Rubber (NASDAQ:GT) had its hold rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a $7.00 target price on the stock, down from their previous target price of $9.00.

Health Catalyst (NASDAQ:HCAT) had its neutral rating reissued by analysts at Cantor Fitzgerald.

International Consolidated Airlines Group (LON:IAG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 460 price target on the stock.

3i Group (LON:III) had its buy rating reissued by analysts at UBS Group AG. UBS Group AG currently has a GBX 3,600 price target on the stock.

ImageneBio (NASDAQ:IMA) had its underperform rating reiterated by analysts at Wedbush.

Imperial Brands (LON:IMB) had its neutral rating reaffirmed by analysts at UBS Group AG. The firm currently has a GBX 3,150 target price on the stock.

Keel Infrastructure (NASDAQ:KEEL) had its buy rating reissued by analysts at Chardan Capital. They currently have a $4.50 price target on the stock.

Land Securities Group (LON:LAND) had its buy rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a GBX 705 target price on the stock.

Lantheus (NASDAQ:LNTH) had its buy rating reiterated by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $115.00 target price on the stock, up from their previous target price of $98.00.

Marks and Spencer Group (LON:MKS) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Mondi (LON:MNDI) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 760 price target on the stock.

Strategy (NASDAQ:MSTR) had its overweight rating reiterated by analysts at Cantor Fitzgerald.

Nature’s Sunshine Products (NASDAQ:NATR) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $33.00 price target on the stock.

National Grid (LON:NG) had its sell rating reaffirmed by analysts at UBS Group AG. They currently have a GBX 1,160 price target on the stock.

NIKE (NYSE:NKE) had its buy rating reiterated by analysts at Sanford C. Bernstein.

Oshkosh (NYSE:OSK) had its hold rating reiterated by analysts at Truist Financial Corporation. They currently have a $176.00 price target on the stock, down from their previous price target of $183.00.

Premier Foods (LON:PFD) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Poolbeg Pharma (LON:POLB) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Rocket Pharmaceuticals (NASDAQ:RCKT) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $11.00 price target on the stock.

Rocket Companies (NYSE:RKT) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $20.00 target price on the stock.

SAB Biotherapeutics (NASDAQ:SABS) had its buy rating reissued by analysts at Rodman & Renshaw. They currently have a $13.00 target price on the stock.

Spirax-Sarco Engineering (LON:SPX) had its buy rating reaffirmed by analysts at UBS Group AG. The firm currently has a £105 price target on the stock.

SSP Group (LON:SSPG) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Safestay (LON:SSTY) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Stoke Therapeutics (NASDAQ:STOK) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $39.00 target price on the stock.

Strawberry Fields REIT (NYSEAMERICAN:STRW) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $15.00 price target on the stock.

Teleflex (NYSE:TFX) had its hold rating reissued by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $143.00 target price on the stock, up from their previous target price of $135.00.

Tandem Diabetes Care (NASDAQ:TNDM) had its buy rating reissued by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $31.00 target price on the stock, down from their previous target price of $35.00.

Ultimate Products (LON:ULTP) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Victrex (LON:VCT) had its sell rating reiterated by analysts at UBS Group AG. The firm currently has a GBX 575 target price on the stock.

Vodafone Group Public (LON:VOD) had its sell rating reissued by analysts at UBS Group AG. UBS Group AG currently has a GBX 95 target price on the stock.

Wendy’s (NASDAQ:WEN) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $6.00 target price on the stock, down from their previous target price of $7.00.

Workspace Group (LON:WKP) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 400 target price on the stock.

TeraWulf (NASDAQ:WULF) had its buy rating reissued by analysts at Rosenblatt Securities. They currently have a $27.00 price target on the stock.